ZyVersa Therapeutics GAAP EPS of -$2.56,
Source: SeekingAlpha
2025-11-19 16:31:43 ET
More on ZyVersa Therapeutics
Read the full article on Seeking Alpha
For further details see:
ZyVersa Therapeutics GAAP EPS of -$2.56,
ZyVersa Therapeutics Inc.
NASDAQ: ZVSA
ZVSA Trading
-76.68% G/L:
$0.3113 Last:
12,453,600 Volume:
$0.55 Open:
ZVSA Latest News
September 10, 2025 07:55:00 am
ZyVersa Therapeutics Highlights Data Reinforcing the Potential of Inflammasome Inhibitors to Attenuate Progression of Type 2 Diabetes and Improve Associated Long-term Cardiovascular Outcomes
September 03, 2025 01:30:25 pm
PRISM Mid-Day Movers: Share Purchases and Wearables Innovation Drive Index Gains
ZVSA Stock Data
$1,619,184
8,014,962
7.09%
7
517010%
Biotechnology & Life Sciences
Healthcare
US
Weston
